Share on LinkedInShare on LinkedIn

ARTICLE · 27 JULY 2011

FDA Draft Guidance On Mobile Medical Applications

On 21 July the FDA released Draft Guidance for Industry and Food and Drug Administration Staff Mobile Medical Applications, a document that I think has great significance for the regulation of the EU eHealth and medical device markets, even if it is presently only a draft.

European UnionInternational Law
Erik Vollebregt
Erik Vollebregt

On 21 July the FDA released Draft Guidance for Industry and Food and Drug Administration Staff Mobile Medical Applications, a document that I think has great significance for the regulation of the EU eHealth and medical device markets, even if it is presently only a draft. If adopted by the FDA its importance will only increase. You can download a copy of the document with my annotations in it over here.

Important guidance for the EU too

I have read the document and the reasoning behind it can, as you will read in the following, almost for a 100% be transplanted to the EU medical devices regulatory environment and the document describes in a very detailed and practical way what is regulated as device (and what not) while giving lots of examples. This is a significant benefit for stakeholders in the EU (and in the US). Why is this document so significant for regulation of eHealth and medical devices markets in the EU?

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from